Compensation of human variability in pulse oximetry

• US 6,882,874 B2
• Filed: 02/15/2002
• Issued: 04/19/2005
• Est. Priority Date: 02/15/2002
• Status: Active Grant

• Current Assignee: Datex-Ohmeda Incorporated (General Electric Company)
• Original Assignee: Datex-Ohmeda Incorporated (General Electric Company)
• Inventors: Huiku, Matti
• Primary Examiner(s): Winakur, Eric F.
• Assistant Examiner(s): Kremer, Matthew J
• Application Number:
  US10/077,196
• Publication Number:
  US 20030176776A1
• Time in Patent Office: 1,159 Days
• Field of Search: 600/331, 600/310, 600321-323, 600/326, 600/328
• US Class Current: 600/331
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes

Abstract

The invention relates to the calibration of a pulse oximeter intended for non-invasively determining the amount of at least two light-absorbing substances in the blood of a subject. In order to bring about a solution by means of which the effects caused by the tissue of the subject can be taken into account in connection with the calibration of a pulse oximeter, initial characterization measurements are carried out for a pulse oximeter calibrated under nominal conditions. Based on the characterization measurements, nominal characteristics are established describing the conditions under which nominal calibration has been defined, and reference data indicating the nominal characteristics are stored. In-vivo measurements are then performed on living tissue and based on the in-vivo measurements and the reference data stored, tissue-induced changes in the nominal characteristics are determined. Subject-specific variation in the in-vivo measurements is compensated for by correcting the nominal calibration on the basis of the tissue-induced changes.

Claims

1. A method for compensating for subject-specific variability in an apparatus intended for non-invasively determining the amount of at least two light-absorbing substances in the blood of a subject and provided with emitter means for emitting radiation at a minimum of two different wavelengths and with detector means for receiving the radiation emitted, the method comprising the steps of

calibrating the apparatus using a nominal calibration,

carrying out initial characterization measurements, said measurements to include measuring radiation emitted by said emitter means and received by the detector means without transmission through tissue,

based on the characterization measurements, establishing nominal characteristics describing conditions under which the nominal calibration is used,

storing reference data indicating the nominal characteristics established,

performing in-vivo measurements on living tissue, wherein radiation emitted by the emitter means through the living tissue and received by the detector means is measured,

based on the in-vivo measurements and the reference data stored, determining tissue-induced changes in the nominal characteristics, and

compensating for subject-specific variation in the in-vivo measurements by correcting the nominal calibration on the basis of the tissue-induced changes.

2. A method according to claim 1, including compensation for effects causing wavelength shift.

3. A method according to claim 2, wherein the compensation for effects causing wavelength shift includes defining subject-specific extinction coefficients for the substances.

4. A method according to claim 3, wherein said establishing step includes determining DC transmission characteristics of the emitter and detector means, spectral characteristics of the emitter and detector means and nominal transmission characteristics for the tissue.

5. A method according to claim 4, wherein said establishing step further includes determining a temperature in which the nominal calibration is used.

6. A method according to claim 5, wherein the extinction coefficients ε

_ij are determined according to the following formula;

${\mathrm{\varepsilon <br><br>}}_{\mathrm{ij}}^{\mathrm{effective}}=\frac{1}{W}<br><br>{\int <br><br>}_{\mathrm{\Delta <br><br>}<br><br>\text{\hspace{1em}<br><br>}<br><br>\mathrm{\lambda <br><br>}}<br><br>{\mathrm{\varepsilon <br><br>}}_j<br><br>\left(\mathrm{\lambda <br><br>}\right)*{\mathrm{LED}}_i<br><br>\left(\mathrm{\lambda <br><br>}<br><br>\left(T\right)\right)*\mathrm{DET}<br><br>\left(\mathrm{\lambda <br><br>}\right)*\mathrm{tissue}<br><br>\left(\mathrm{\lambda <br><br>}\right)<br><br>\partial <br><br>\mathrm{\lambda <br><br>},$

where ε

_ij^effective is the effective extinction for the emitter means as defined by the integration over an emission spectrum LED_i(λ

) of the emitter means, DET(λ

) represents a spectral sensitivity of the detector means, tissue(λ

) is a spectral transmission of radiation through the tissue, ε

_j is the extinction coefficient of the substance, T is a temperature, λ

is a wavelength of the radiation, W is a normalization factor, and i and j are matrix indices.

7. A method according to claim 6, wherein

the step of establishing nominal characteristics includes defining a nominal extinction matrix with a nominal extinction coefficient for each substance/wavelength pair, and

the step of determining tissue-induced changes includes updating the nominal extinction matrix, whereby the updated matrix includes the subject-specific extinction coefficients to be used in the Lambert-Beer model.

8. A method according to claim 7, wherein the nominal extinction matrix is determined according to the following formula ${\varepsilon }_{}^{}$

ijeffective=1W⁢

∫

Δ

⁢

 

⁢

λ

⁢

ɛ

j⁡

(λ

)*LEDi⁡

(λ

⁡

(T))*DET⁡

(λ

)⁢

∂

λ

where the integration is over the emission spectrum LED_i(λ

) of the emitter means, DET(λ

) represents the spectral sensitivity of the detector means;

ε

_j is the extinction coefficient of the substance, T is the temperature, and i and j are matrix indices.

9. A method according to claim 7, wherein the step of establishing nominal characteristics further includes determining a first shift matrix, the elements of which indicate a relative change in each extinction coefficient, assuming that the slope of the term tissue(λ

) has a fixed value deviating from zero.

10. A method according to claim 9, wherein the step of determining tissue-induced changes in the nominal characteristics includes defining (1) the slope of the term tissue(λ

) and (2) the subject-specific extinction coefficients based on the shift matrix and the slope defined.

11. A method according to claim 6, wherein

the step of establishing nominal characteristics further includes defining temperature dependence of the emitter and detector means, and

said compensating step includes temperature compensation for the emitter and detector means.

12. A method according to claim 11, wherein the step of establishing nominal characteristics further includes determining a second shift matrix the elements of which indicate a relative change of each extinction coefficient for a predetermined wavelength shift.

13. A method according to claim 12, wherein the step of determining tissue-induced changes in the nominal characteristics includes

defining a wavelength shift caused by temperature and

defining subject-specific coefficients based on the shift matrix and the wavelength shift defined.

14. A method according to claim 1, including compensation for effects internal to the tissue.

15. A method according to claim 14, wherein the compensation for effects internal to the tissue includes defining a subject-specific transformation used to transform in-vivo measurement results to the Lambert-Beer model.

16. A method according to claim 15, wherein the method further includes the steps of

storing an average transformation measured for a great number of subjects and

based on the tissue-induced changes, updating the average transformation, whereby the updated transformation represents the subject-specific transformation.

17. A method according to claim 1, including both compensation for effects causing wavelength shift and for effects internal to the tissue.

18. A method according to claim 17, wherein the compensation for effects causing wavelength shift includes defining subject-specific extinction coefficients for the substances, and the compensation for effects internal to the tissue includes defining a subject-specific transformation used to transform in-vivo measurement results to the Lambert-Beer model.

19. A method according to claim 18, wherein

the step of defining nominal characteristics includes calculating nominal values for the Functional Light Transmission (FLT) of the apparatus,

the step of determining tissue-induced changes includes calculating new values for the Functional Light Transmission (FLT) of the apparatus, and

the step of compensating includes determining the subject-specific transformation on the basis of the nominal and new values.

20. A method according to claim 18, wherein

the step of defining nominal characteristics includes calculating nominal values for function F_kl of the apparatus,

the step of determining tissue-induced changes includes calculating new values for the function F_kl of the apparatus, and

the step of compensating includes determining the subject-specific transformation on the basis of the nominal and new values,

wherein the function F_kl corresponds to the ratio $\frac{f_a}{}$

(μ

ak-μ

vk)+μ

vkfa⁡

(μ

al-μ

vl)+μ

vl,

 

where μ

_v and μ

_a are the absorption coefficients of venous and arterial blood, respectively, as determined in the Lambert-Beer domain, f_a is the volume fraction of arterial blood, and the superscripts k and l indicate the wavelength.

21. A method according to claim 20, wherein the nominal and new values for the Function F_kl are calculated on the basis of measured fluctuation of the DC component of the radiation received by the detector means.

22. A method according to claim 20, wherein

the step of determining tissue-induced changes includes calculating a first approximation for the amount of the substances, and

the step of compensating includes utilizing the first approximation for determining the subject-specific transformation.

23. A method according to claim 1, wherein the at least two light absorbing substances include oxyhemoglobin (HbO2) and reduced hemoglobin (RHb).